Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR

INTRODUCTION: Pre-emptive testing of pharmacogenetically relevant single-nucleotide polymorphisms can be an effective tool in the prevention of adverse drug reactions and therapy resistance. However, most of the tests are not used as standard in routine care in Germany because of lacking evidence fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huebner, Tatjana, Steffens, Michael, Linder, Roland, Fracowiak, Jochen, Langner, Daria, Garling, Marco, Falkenberg, Felix, Roethlein, Christoph, Gomm, Willy, Haenisch, Britta, Stingl, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213853/
https://www.ncbi.nlm.nih.gov/pubmed/32345696
http://dx.doi.org/10.1136/bmjopen-2019-032624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213853/
https://www.ncbi.nlm.nih.gov/pubmed/32345696
http://dx.doi.org/10.1136/bmjopen-2019-032624

Ejemplares similares